IE1-pp65 recombinant protein from human CMV combined with a nanoparticulate carrier, SMBV, as a potential source for the development of anti-human CMV adoptive immunotherapy
| Autor: | Vaz-Santiago, J. 1, Lulé, J. 2, Rohrlich, P. 3, Kravtzoff, R. 1, Le Roy, E. 2, Davignon, J.-L. 2, Betbeder, D. 1, Davrinche, C. 2, ⁎ |
|---|---|
| Zdroj: | In Cytotherapy January 2002 4(1):11-19 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect